Clinical Trials
3 trialsNCT02500641 2019-06-21
FORWARD
Menarini International Operations Luxembourg SA
Phase 4 Completed
NCT00607152 2014-05-08
Rasburicase (Fasturtec) Registration Trial
Sanofi
Phase 3 Terminated
NCT00230178 2010-01-12
Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome
Sanofi
Phase 3 Completed